Chemed (CHE) Enterprise Value (2009 - 2026)

Chemed has reported Enterprise Value for 18 years, with the latest figure at -$40.2 million in Q2 2026.

• Enterprise Value for Q2 2026 came in at -$40.2 million, up 83.91% year-over-year; the trailing twelve-month figure through Jun 2026 was -$40.2 million (up 83.91% YoY), and the FY2025 annual result was -$74.5 million, up 58.22% from the prior year.
• Enterprise Value slipped to -$40.2 million in Q2 2026, from -$16.9 million in the prior quarter.
• Over five years, Enterprise Value peaked at -$7.8 million in Q3 2022 and troughed at -$313.3 million in Q1 2024.
• A 5-year average of -$133.5 million and a median of -$144.8 million in 2023 frame the typical range for Enterprise Value.
• The widest annual swing landed in 2022, when Enterprise Value surged 91.36%; it then sank 2125.29% in 2023.
• A 5-year view of Enterprise Value shows it stood at -$74.1 million in 2022, then plunged by 256.09% to -$264.0 million in 2023, then surged by 32.43% to -$178.4 million in 2024, then soared by 58.22% to -$74.5 million in 2025, then soared by 46.02% to -$40.2 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were -$40.2 million in Q2 2026, -$16.9 million in Q1 2026, and -$74.5 million in Q4 2025.